Table 1.
Clinical variables of our subjects
| Clinical variables | |
| Patients (N) | 113 |
| Age (years old) | 58.8 ± 8.5 |
| Age (years old) (range) | 39–82 |
| Waist circumference (cm) | 87.7 ± 8.5 |
| Heart rate (beats/minute) | 63.4 ± 10.1 |
| Systolic BP (mmHg) | 131.3 ± 14.0 |
| Diastolic BP (mmHg) | 83.6 ± 9.5 |
| Mean BP (mmHg) | 99.5 ± 10.5 |
| Total-cholesterol (mg/dL) | 210.1 ± 35.7 |
| LDL-cholesterol (mg/dL) | 125.8 ± 32.8 |
| hDL-cholesterol (mg/dL) | 53.6 ± 12.7 |
| Triglycerides (mg/dL) | 125.3 ± 7.5 |
| Fasting plasma glucose (mg/dL) | 101.4 ± 6.1 |
| Fasting Insulin (µU/mL) | 5.40 ± 0.32 |
| HOMA-IR | 1.35 ± 0.08 |
| HbA1c (%) | 5.32 ± 0.32 |
| AGEs (U/mL) | 9.17 ± 2.69 |
| Testosterone (ng/mL) | 4.84 ± 0.29 |
| Blood urea nitrogen (mg/dL) | 15.2 ± 3.1 |
| Creatinine (mg/dL) | 0.82 ± 0.05 |
| Creatinine clearance (mL/min) | 94.0 ± 22.7 |
| Uric acid (mg/dL) | 6.22 ± 1.14 |
| Hs-CRP (mg/l) | 0.61 ± 0.04 |
| Current smoker (N) | 17 |
BP, blood pressure; LDL-cholesterol, low-density lipoprotein-cholesterol; HDL-cholesterol, high-density lipoprotein-cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; HbA1c, glycosylated hemoglobin; AGEs, advanced glycation end products; Hs-CRP, high sensitive C-reactive protein; N, number.